Chemotherapy and immune checkpoint inhibitors in a case of SMARCA4-dUT: a case report and review of literature
SMARCA4-deficient undifferentiated tumors (SMARCA4-dUT) are infrequently occurring
aggressive neoplasms found predominantly in young male smokers. These tumors are …
aggressive neoplasms found predominantly in young male smokers. These tumors are …
SMARCA4-deficient central nervous system metastases: A case series and systematic review
M Morris, K Ararat, H Cutshall, M Gokden… - … of Neuropathology & …, 2024 - academic.oup.com
SMARCA4 alterations can be encountered in a variety of human neoplasms, and
metastases to the central nervous system (CNS) are rare, offering a challenge to …
metastases to the central nervous system (CNS) are rare, offering a challenge to …
Artificial intelligence platform, RADR®, aids in the discovery of DNA damaging agent for the ultra-rare cancer Atypical Teratoid Rhabdoid Tumors
J McDermott, D Sturtevant, U Kathad… - Frontiers in Drug …, 2022 - frontiersin.org
Over the last decade the next-generation sequencing and 'omics techniques have become
indispensable tools for medicine and drug discovery. These techniques have led to an …
indispensable tools for medicine and drug discovery. These techniques have led to an …
[HTML][HTML] TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
Abstract SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized
as a distinct subtype based on subtle differences in its clinical, morphological, and …
as a distinct subtype based on subtle differences in its clinical, morphological, and …
Case report: The first account of undifferentiated sarcoma with epithelioid features originating in the pleura
LX Xiao, L Liu, W Deng - Frontiers in Medicine, 2024 - frontiersin.org
Undifferentiated epithelioid sarcoma (USEF) is a rare subtype of undifferentiated soft tissue
sarcoma that presents unique challenges in clinical diagnosis and treatment. Here, we …
sarcoma that presents unique challenges in clinical diagnosis and treatment. Here, we …
Unravelling switch/sucrose non-fermentable (SWI-SNF) complex-deficient thoracic tumours: a clinicopathological comparative on undifferentiated tumours and non …
R Sood, A Tandon, W Khatoon… - Journal of Clinical …, 2024 - jcp.bmj.com
Aims This study was undertaken to compare and expand the clinicopathological
characteristics of SMARCA4-deficient thoracic undifferentiated tumour (SMARCA4-dUT) and …
characteristics of SMARCA4-deficient thoracic undifferentiated tumour (SMARCA4-dUT) and …
Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and …
N Ji, Y Lee, SH Lee, HS Kim - Anticancer research, 2024 - ar.iiarjournals.org
Background/Aim: Both mesonephric adenocarcinoma (MA) and mesonephric-like
adenocarcinoma (MLA) express thyroid transcription factor 1 (TTF1). TTF1 is also …
adenocarcinoma (MLA) express thyroid transcription factor 1 (TTF1). TTF1 is also …
[HTML][HTML] Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma
L Zhang, T Sun, XY Wu, FM Fei… - World Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Hepatocellular carcinoma (HCC) is a common malignancy worldwide, and
the mortality rate continues to rise each year. SMARCA4 expression has been associated …
the mortality rate continues to rise each year. SMARCA4 expression has been associated …